Search Login Register

pegvisomant Summary

Description: is a genetically engineered analogue of human growth hormone that functions as a growth hormone-receptor antagonist; used to treat Acromegaly;

Also Known As: B-2036 PEG; B2036-PEG; Pfizer brand of pegvisomant; Somavert

Networked: 210 relevant articles (45 outcomes, 49 trials/studies) for this Drug

Key Diseases for which pegvisomant is Relevant

  1. Acromegaly : 36 outcomes 39 studies in 170 results
  2. Neoplasms (Cancer) : 2 outcomes 7 studies in 24 results
  3. Pituitary Neoplasms (Pituitary Adenoma) : 2 outcomes 2 studies in 15 results
  4. Insulin Resistance : 2 outcomes 1 study in 4 results
  5. Adenoma (Adenomas) : 1 outcome 2 studies in 6 results
Show All >>

Drugs Related to pegvisomant

  1. Insulin-Like Growth Factor I (IGF-1)
  2. Somatostatin (Somatotropin Release-Inhibiting Factor)
  3. Octreotide (Sandostatin)
  4. Insulin (Novolin)
  5. pegvisomant
  6. Somatotropin Receptors (Growth Hormone Receptor)
  7. Glucose (Dextrose)
  8. Dopamine Agonists (Dopamine Agonist)
  9. cabergoline
  10. Growth Hormone (Somatotropin)
Show All >>

Therapies Related to pegvisomant

  1. Radiotherapy
  2. Drug Therapy (Chemotherapy)
  3. Injections
  4. Heterologous Transplantation (Xenotransplantation)
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.